Newsletter Subject

Prone Positioning Falls Flat for Weaning COVID Patients Off ECMO

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Fri, Dec 1, 2023 11:50 PM

Email Preheader Text

Daily Headlines Friday, December 01, 2023 Today's Top Stories for {NAME} THE BREAK ROOM CME SPOTLIGH

[MEDPAGE TODAY]( Daily Headlines Friday, December 01, 2023 Today's Top Stories for {NAME} [CRITICAL CARE]( [Prone Positioning Falls Flat for Weaning COVID Patients Off ECMO]( [NEUROLOGY]( [Rare Syndrome After COVID Vaccines Described]( [ENDOCRINOLOGY]( ['Alexa, Titrate My Insulin': AI App Boosts Glycemic Control in Randomized Trial]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Employing Tools in Clinical Practice to Accelerate Prompt, Accurate Diagnosis and Risk Assessment in MDS]( [NEPHROLOGY]( [Two-Week Prophylaxis May Prevent Hep C After Kidney Transplant]( [ONCOLOGY/HEMATOLOGY]( [Let's Talk Drug Prices; Restoring the Sense of Touch; Learning From Tumors in a Dish]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [VIDEO]( [Managing the Safety of Newer Atopic Dermatitis Treatments]( CME SPOTLIGHT [Expert Strategies for Identification and Management of CAR T-Cell Related Adverse Events]( [VIDEO]( [Biologics Offer New Options in Atopic Dermatitis]( [OPINION]( [A World AIDS Day Reminder: No One Should Be Left Behind]( [MEETING COVERAGE]( [Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancer]( CME SPOTLIGHT [Applying the Latest Clinical Evidence and Guideline Recommendations for CAR T-cell Therapy in Non-Hodgkin Lymphoma]( [POP MEDICINE]( [Swapping the White Coat for a Space Suit]( [ENDOCRINOLOGY]( [Year in Review: Obesity]( [SURGERY]( [VTE Risk After Joint Replacement: Does Anticoagulant Choice Matter?]( CME SPOTLIGHT [Applying the Latest Evidence for Anemia Management in Patients With Lower-Risk Myelodysplastic Syndrome, Myelofibrosis, and Beta Thalassemia]( [ACR READING ROOM]( [Brepocitinib Makes Big Impact in Psoriatic Arthritis]( [ACR READING ROOM]( [Safety, Efficacy of Brepocitinib, a TYK2/JAK1 Inhibitor for Patients With Psoriatic Arthritis]( [CLINICAL CHALLENGES]( [Clinical Challenges: New Hope in Management of Neurofibromatosis]( CME SPOTLIGHT [Watch and Wait or Initiate: Providing Timely Access to Novel Therapies for Chronic Lymphocytic Leukemia]( [ONCOLOGY/HEMATOLOGY]( [Year in Review: Follicular Lymphoma]( [CLINICAL CHALLENGES]( [Clinical Challenges: Test Your Knowledge of Axial Spondyloarthritis]( [CLINICAL CHALLENGES]( [Clinical Challenges: Current Treatment for Axial Spondyloarthritis]( CME SPOTLIGHT [Advancing Collaborative Multiple Myeloma Care Coordination Among Oncology Centers]( [PRACTICE MANAGEMENT]( [The Five Things That Worry Lawmakers Most About AI in Healthcare]( # Weekly Survey [Concerned About China's Latest Outbreak?]( Chinese health officials have confirmed an [uptick in respiratory illness]( there, which they attribute to post-lockdown 'immunity debt.'[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-12-01&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.